Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioelectric Research Corporation has developed and launched the ODIN 1®, a medical device that delivers specific electrical waveforms to achieve anti-microbial, anti-inflammatory, and analgesic effects. The company focuses on non-pharmacological approaches to treat wounds, pain—including opiate withdrawal—and other conditions. Clinical results are not detailed publicly but the product is available commercially.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioelectric Research.